Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Eligix cleared to initiate pivotal trial of DLI purification technology

July 28, 1999

AHP's pneumococcal conjugate vaccine receives priority review status

July 27, 1999

ProdiGene patents edible vaccines

July 23, 1999

Inhibitors of Src family SH2 domains in early-stage development at Boehringer Ingelheim

July 22, 1999

Novartis exercises option to license complement inhibitor from Avant

July 21, 1999

Rotavirus vaccine temporarily suspended due to reports of intussusception

July 20, 1999

Takeda patents inhibitors of ICAM-1/ELAM-1 expression for immune, autoimmune disorders

July 20, 1999

Cantab's therapeutic vaccine for genital warts enters phase II trials

July 20, 1999

New topical ciclosporin formulation effective for site-specific immunosuppression

July 20, 1999

Tanox tests Hu-901 in peanut allergy

July 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...